Clinical Trials Logo

Glucose Metabolism Disorders clinical trials

View clinical trials related to Glucose Metabolism Disorders.

Filter by:

NCT ID: NCT03771066 Recruiting - Insulin Sensitivity Clinical Trials

Bisphenol A and Muscle Insulin Sensitivity

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

This study examine oral bisphenol A consumption on muscle insulin sensitivity and hepatic glucose suppression. Half of the participants will receive a diet plus BPA and the other half will receive a diet plus no bisphenol A.

NCT ID: NCT03765008 Withdrawn - Clinical trials for Glucose Metabolism Disorders

The Effect of Water Intake on Glucose Regulation

INDIGO-I
Start date: February 11, 2019
Phase: N/A
Study type: Interventional

There is a growing body of evidence suggesting low water intake and elevated levels of the hormone vasopressin exacerbate glucose regulation. This project will examine the physiological mechanism by which low water intake impairs glucose homeostasis. In the current proposal we aim to: 1) quantify the degree of glucose impairment as a response to elevated vasopressin due to low water intake and 2) identify the physiological mechanism by which elevated vasopressin, as a response to low water intake, impairs glucose regulation

NCT ID: NCT03685773 Withdrawn - Clinical trials for Diabetes Mellitus, Type 2

The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients

Start date: April 21, 2019
Phase: Phase 2
Study type: Interventional

It is believed that important brain centers send signals through the vagus nerve to the liver to suppress the amount of glucose (sugar) that gets produced. People who have received liver transplants have had their vagus nerve cut during transplantation, and many of these individuals have diabetes at one year post-transplant. The goals of this study are: to see whether metabolic control centers in the brain can still be activated normally with the medication diazoxide in patients who have had a liver transplant, and to understand whether disrupting the vagus nerve would result in excess glucose being produced by the liver (ie. a potential mechanism for why these patients develop diabetes).

NCT ID: NCT03682640 Recruiting - Diabetes Mellitus Clinical Trials

Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes

AIDIT
Start date: September 2018
Phase: Phase 2
Study type: Interventional

Increasing evidences suggest that infections are important etiological factors for the development of Type 1 Diabetes (T1D). The overall hypothesis of the study is that the treatment of children, during the first year after diagnosis of T1D with Azithromycin, combined with repeated episodes of intensified insulin treatment to induce maximal beta-cell rest, and dietician support to promote dietary habits that minimize the likelihood of bacterial reflux from the duodenum to the pancreatic duct, will lead to preservation of beta cell function. This trial will examine whether the AIDIT protocol initiated within one week from diagnosis could preserve insulin production in children with Type 1 Diabetes.

NCT ID: NCT03675360 Completed - Diabetes Clinical Trials

Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial

ADEPT
Start date: September 25, 2018
Phase: N/A
Study type: Interventional

The proposed randomized controlled trial will test the effect of a low-carbohydrate diet on hemoglobin A1c among individuals with elevated hemoglobin A1c that are within the range of prediabetes or diabetes. Results may provide evidence about the role of carbohydrate restriction in individuals with or at high risk of type 2 diabetes.

NCT ID: NCT03671161 Completed - Clinical trials for Diabetes Mellitus, Type 1

Flash Glucose Measure System and Continuous Subcutaneous Insulin Infusion Therapy in Poorly Controlled Diabetes Type 1 Patients

FREESTYLE
Start date: January 1, 2016
Phase: N/A
Study type: Interventional

Patients with diabetes type 1 with poor glycemic control will be switched to insulin pump and FGM system (Flash Glucose Monitoring) during 6 months, correlated to the hypothesis that they could benefit from this intervention by being reengaged in diabetes self-management.

NCT ID: NCT03623139 Completed - Clinical trials for Diabetes Mellitus, Type 2

Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education in Type 2 Diabetes

Start date: September 28, 2018
Phase: N/A
Study type: Interventional

The aim of the study is to examine the health benefits of adding a concept in basic carbohydrate counting (BCC) to the routine outpatient nutritional education for adult patients with type 2 diabetes. The study hypothesis is that training and education in the BCC concept will improve glycaemic control either by reducing HbA1c or the average plasma glucose variability more than offering the routine dietary care as a stand-alone dietary treatment.

NCT ID: NCT03623113 Completed - Type1diabetes Clinical Trials

The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 Diabetes

Start date: September 28, 2018
Phase: N/A
Study type: Interventional

The study is designed to evaluate two different dietitian-led self-management approaches in carbohydrate counting compared to routine dietary care (control) on glycaemic control in adult patients with type 1 diabetes: 1. The basic carbohydrate counting concept aims at improving carbohydrate counting accuracy and day-to-day consistency of carbohydrate intake (the BCC intervention) 2. The advanced carbohydrate counting concept aims at improving prandial insulin dose accuracy using an automated bolus calculator (the ABC-ACC intervention) The main hypothesis is that structured training and education in either the BCC concept or the ABC-ACC concept will reduce HbA1c or the average glucose variability more than routine dietary education.

NCT ID: NCT03613688 Recruiting - Clinical trials for Glucose Metabolism Disorders

Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control

Start date: September 20, 2018
Phase: N/A
Study type: Interventional

This is a randomized, controlled, cross-over study on the effects of consumption of Deepure puerh tea extract (PTE) on glucose tolerance and metabolic markers.

NCT ID: NCT03577964 Active, not recruiting - Clinical trials for Glucose Metabolism Disorders

Development of Pneumonia Due to Alveolar Glucose Levels in Systemic Hyperglycemia

Start date: September 1, 2017
Phase:
Study type: Observational

Incidence of Pneumonia in Patients with high systemic glucose levels.